Connection

Adam Brufsky to Aged, 80 and over

This is a "connection" page, showing publications Adam Brufsky has written about Aged, 80 and over.
Connection Strength

0.050
  1. Prevalence and determinants of end-of-life chemotherapy use in patients with metastatic breast cancer. Breast J. 2017 Nov; 23(6):718-722.
    View in: PubMed
    Score: 0.020
  2. Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19. J Med Virol. 2021 01; 93(1):409-415.
    View in: PubMed
    Score: 0.006
  3. Pathologist's health-care value in the triage of Oncotype DX® testing: a value-based pathology study of tumour biology with outcomes. Histopathology. 2018 Oct; 73(4):692-700.
    View in: PubMed
    Score: 0.005
  4. Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103). J Clin Oncol. 2018 09 01; 36(25):2621-2629.
    View in: PubMed
    Score: 0.005
  5. Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer. Am J Clin Pathol. 2018 Mar 07; 149(4):332-343.
    View in: PubMed
    Score: 0.005
  6. TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer. Breast Cancer Res Treat. 2017 Aug; 164(3):649-658.
    View in: PubMed
    Score: 0.005
  7. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases. Arch Pathol Lab Med. 2006 Oct; 130(10):1516-21.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.